Galit Alter
| |
|---|---|
| Born | 1976 or 1977 (age 46–47)[2] |
| Education | Ph.D. from McGill University[3] |
| Awards | MGH Research Scholars Award (twice)[1] |
| Scientific career | |
| Fields | immunology, infectious diseases |
| Institutions | Harvard Medical School Ragon Institute |
| Website | ragoninstitute |
Galit Alter is an immunologist and virologist, professor of medicine at Harvard Medical School, and group leader at the Ragon Institute of MGH, MIT and Harvard. She is known for her work on the expansion of particular natural killer cell subtypes in response to HIV-1 infection.[4][5] She has also contributed to the understanding of how SARS-CoV-2 antibody titers correlate with sustained humoral protection, including identifying coordinated immune cell-antibody signatures that may predict COVID-19 infection outcome.[2][6]
In October 2022 she became Vice President of Immunology in Infectious Disease Research at Moderna[7]
| International |
|
|---|---|
| National |
|
| Academics |
|
 | This biographical article about a scientist is a stub. You can help Wikipedia by expanding it. |
